Aricept (donepezil) has been approved by the FDA for treating all stages of Alzheimer's -- mild, moderate, and severe. It can take up to 3 weeks for any positive effects to appear. Recent studies show that it may be helpful for several years, especially in combination with Namenda (memantine); and may delay or prevent the development of serious behavioral symptoms.

Aricept (donepezil) approved for all stages of Alzheimer's
INDICATIONS ARICEPTĀ® is indicated for the treatment of dementia of the Alzheimer's type. Efficacy has been demonstrated in patients with mild to moderate Alzheimer's Disease, as well as in patients
Aricept (donepezil) for Severe Alzheimer's
3 April 2006. With the exception of the glutamate antagonist memantine, the only drug treatments currently approved by the U.S. Food and Drug Administration for treating Alzheimer disease are cholines